These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34078824)

  • 21. Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1022-1037. PubMed ID: 34962070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Jia S; Zhao Y; Yang J; Zhao X; Xu H; Gao R; Wang Q; Li J; Yuan J; Yang Y
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):793-799. PubMed ID: 30637931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right ventricular branch compromise after percutaneous coronary intervention and baseline chronic kidney disease: A high-risk combination associated with long-term prognoses in acute inferior myocardial infarction.
    Setoyama K; Sonoda S; Naka Y; Okabe H; Inoue K; Miura T; Anai R; Araki M; Fujino Y; Takeuchi M; Otsuji Y; Kataoka M
    J Cardiol; 2021 Nov; 78(5):463-470. PubMed ID: 34226087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
    Bagai A; Lu D; Lucas J; Goyal A; Herzog CA; Wang TY; Goodman SG; Roe MT
    J Am Heart Assoc; 2018 Dec; 7(24):e010394. PubMed ID: 30514137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of zotarolimus- and everolimus-eluting stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention.
    Ahmed K; Jeong MH; Chakraborty R; Ahmed S; Hong YJ; Sim DS; Park KH; Kim JH; Ahn Y; Kang JC; Cho MC; Kim CJ; Kim YJ;
    J Cardiol; 2014 Oct; 64(4):273-8. PubMed ID: 24631465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Impact of Polyvascular Disease in Patients With Acute Myocardial Infarction in the Contemporary Era of Percutaneous Coronary Intervention　- Insights From the Japan Acute Myocardial Infarction Registry (JAMIR).
    Arai R; Okumura Y; Murata N; Fukamachi D; Honda S; Nishihira K; Kojima S; Takegami M; Asaumi Y; Yamashita J; Saji M; Hibi K; Takahashi J; Sakata Y; Takayama M; Sumiyoshi T; Ogawa H; Kimura K; Yasuda S;
    Circ J; 2024 May; 88(6):911-920. PubMed ID: 38008436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
    Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial.
    Gargiulo G; Santucci A; Piccolo R; Franzone A; Ariotti S; Baldo A; Esposito G; Moschovitis A; Windecker S; Valgimigli M
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):E73-E84. PubMed ID: 28198091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic kidney disease's impact on revascularization and subsequent major adverse cardiovascular events in patients with chronic coronary syndrome.
    Farag SI; Mostafa SA; Kabil H; Elfaramawy MR
    Indian Heart J; 2024; 76(1):22-26. PubMed ID: 38000533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies.
    Kuno T; Claessen B; Cao D; Chandiramani R; Guedeney P; Sorrentino S; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Rau V; Ruster K; Wang J; Valgimigli M; Mehran R
    J Thromb Thrombolysis; 2021 Aug; 52(2):419-428. PubMed ID: 33709255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.
    Amon J; Wong GC; Lee T; Singer J; Cairns J; Shavadia JS; Granger C; Gin K; Wang TY; van Diepen S; Fordyce CB
    J Am Heart Assoc; 2022 Sep; 11(17):e025572. PubMed ID: 36056738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with end-stage renal disease requiring hemodialysis benefit from percutaneous coronary intervention after non-ST-segment elevation myocardial infarction.
    Fu Y; Sun H; Zuo K; Guo Z; Xu L; Chen M; Wang L
    Intern Emerg Med; 2022 Jun; 17(4):1087-1095. PubMed ID: 35018545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.
    Tajti P; Karatasakis A; Danek BA; Alaswad K; Karmpaliotis D; Jaffer FA; Choi JW; Yeh RW; Patel M; Mahmud E; Burke MN; Krestyaninov O; Khelimskii D; Toma C; Doing AH; Uretsky B; Koutouzis M; Tsiafoutis I; Wyman RM; Garcia S; Holper E; Xenogiannis I; Rangan BV; Banerjee S; Ungi I; Brilakis ES
    J Invasive Cardiol; 2018 Nov; 30(11):E113-E121. PubMed ID: 30218557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Incomplete Revascularization after Percutaneous Coronary Intervention Following Acute Coronary Syndrome: Focus on CKD Patients.
    Cardi T; Kayali A; Trimaille A; Marchandot B; Ristorto J; Hoang VA; Hess S; Kibler M; Jesel L; Ohlmann P; Morel O
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31174280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry.
    Watanabe Y; Mitomo S; Naganuma T; Takagi K; Kawamoto H; Matsuoka S; Chieffo A; Montorfano M; Nakamura S; Colombo A
    Scand Cardiovasc J; 2022 Dec; 56(1):236-242. PubMed ID: 35799477
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention.
    Bloom JE; Dinh DT; Noaman S; Martin C; Lim M; Batchelor R; Zheng W; Reid C; Brennan A; Lefkovits J; Cox N; Duffy SJ; Chan W
    Catheter Cardiovasc Interv; 2021 May; 97(6):E801-E809. PubMed ID: 33325620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions (from the Japanese Multicenter Registry).
    Naganuma T; Tsujita K; Mitomo S; Ishiguro H; Basavarajaiah S; Sato K; Kobayashi T; Obata J; Nagamatsu S; Yamanaga K; Komura N; Sakamoto K; Yamamoto E; Izumiya Y; Kojima S; Kaikita K; Ogawa H; Nakamura S
    Am J Cardiol; 2018 Jun; 121(12):1519-1523. PubMed ID: 29627112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 40. Feasibility, Safety, and Long-Term Outcomes of Zero-Contrast Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.
    Shibata K; Wakabayashi K; Ishinaga T; Morimura M; Aizawa N; Suzuki T; Furuya T; Sato C; Nishikura T; Ikeda N; Kikuchi M; Tanno K; Shinke T; Izumizaki M
    Circ J; 2022 Apr; 86(5):787-796. PubMed ID: 35153272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.